Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12
Review
Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,553 | Dovepress* | 6,272+ | 1,398 | 7,670 | |
| PubMed Central* | 2,281 | 489 | 2,770 | ||
| Totals | 8,553 | 1,887 | 10,440 | ||
| *Since 3 December 2019 | |||||
View citations on PubMed Central and Google Scholar